Andrew Shepherd

Andrew Shepherd's work experience includes:

- Scientific Director at Envision Pharma Group from 2018 to present.

- Senior Medical Writer at Caudex Medical from 2009 to 2018. Responsibilities included working on publications and medical communications in various specialties, delivering internal training, and holding additional roles such as staff representative and committee member.

- Postdoctoral Research Associate at Krebs Institute, Sheffield from 2007 to 2009.

Andrew Shepherd has a strong educational background in both natural sciences and microbial genetics. Andrew obtained a Bachelor's degree in Natural Sciences from the University of Cambridge in 1999. Andrew then pursued further education at Trinity Hall, Cambridge, where they obtained a Master of Arts in Natural Sciences with a specialization in genetics in 2002.

Andrew's passion for genetics led him to pursue a Doctor of Philosophy (PhD) at Sheffield University's Department of MBB. Andrew completed their PhD in Microbial Genetics in 2006.

In addition to their formal education, Andrew has also obtained several certifications to enhance their skills and knowledge in various fields. Notable certifications include their Certified Medical Publication Professional (CMPP) certification obtained from the International Society for Medical Publication Professionals in 2015. Andrew has also completed courses in drug development, cyber security, digital marketing, and other healthcare-related topics through platforms such as Coursera, FutureLearn Ltd, and edX.

It's also worth mentioning that Andrew obtained a Foundation certificate in health and safety from the Health and Safety Executive in 2009. Lastly, they have completed a course in introduction to Philosophy through the University of Edinburgh, although the exact completion date is unknown.

Overall, Andrew Shepherd's education history showcases their dedication to academic excellence and their continuous pursuit of knowledge and skills in various fields.